Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2692 studies found for:    ovarian cancer
Show Display Options
Rank Status Study
1 Recruiting Writing About Experiences With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Writing about ovarian cancer
2 Withdrawn Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Carboplatin and / or taxol chemotherapy
3 Completed Elizabeth Registry for Low Grade Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
4 Active, not recruiting Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Questionnaire;   Behavioral: Interview
5 Recruiting Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: PET/CT(3hours]
6 Terminated Weekly Topotecan Therapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Topotecan
7 Completed Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Imatinib Mesylate;   Drug: Docetaxel
8 Completed Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
Condition: Ovarian Cancer
Intervention: Procedure: DCE-MRI scans
9 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
10 Unknown  A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Paclitaxel, Carboplatin and Vorinostat
11 Unknown  Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
Condition: Ovarian Cancer
Intervention:
12 Completed Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
Condition: Ovarian Cancer
Intervention: Behavioral: Fertility-Sparing Survey
13 Completed Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: protein expression analysis;   Other: immunohistochemistry
14 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
15 Terminated NYU Ovarian Cancer Early Detection Program Blood and Genetics
Condition: Ovarian Cancer
Intervention:
16 Completed Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status
Condition: Ovarian Cancer
Interventions: Drug: Veliparib;   Drug: Topotecan
17 Unknown  Hypodontia and Ovarian Cancer
Conditions: Ovarian Cancer;   Hypodontia;   Breast Cancer;   Colon Cancer
Intervention:
18 Completed
Has Results
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Bendamustine HCL
19 Completed First Line Ovarian Cancer Treatment - Cohort Study
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Bevacizumab
20 Terminated Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.